Previous 10 |
home / stock / xphy:cc / xphy:cc news
XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) , a bioscience accelerator focused on next-generation drug delivery, diagnostic and new active pharmaceutical ingredient investment opportunities, has announced that, further to its news release of March 25, 2022, it has closed the f...
VANCOUVER, BC and UTTENWEILER, GERMANY / ACCESSWIRE / March 31, 2022 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company") is pleased to announce that further to its news release of March 25, 2022, it has closed the first tranche of its private placem...
News, Short Squeeze, Breakout and More Instantly...
Xphyto Therapeutics Corp. - Common Shares Company Name:
XPHY:CC Stock Symbol:
CNQC Market:
Toronto, Ontario--(Newsfile Corp. - Le 10 novembre/November 2022) - XPhyto Therapeutics Corp. (XPHY) has announced a name and symbol change to BioNxt Solutions Inc. (BNXT). Shares will begin trading under the new name and symbol and with a new CUSIP number on November 14, 2022. Disclos...
XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) has announced a name change. According to the company, effective next Monday, Nov. 14, 2022, the company’s name will change from XPhyto Therapeutics Corp. to BioNxt Solutions Inc. Along with the name change, the com...
VANCOUVER, BC / ACCESSWIRE / November 10, 2022 / XPhyto Therapeutics Corp. (" XPhyto " or the " Company ") (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) is pleased to announce that effective November 14, 2022, the Company's name will change from "XPhyto Therapeutics Corp." to " BioNxt Solutions Inc. ". A...